Patents by Inventor Yu Xia

Yu Xia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260319315
    Abstract: A variable light transmission device is disclosed, the variable light transmission device comprising two light transmissive electrode layer and a microcell layer having a plurality of microcells. Each of the plurality of microcells includes a first type of electrically charged pigment particles and a second type of electrically charged pigment particles, a charge control agent, and a non-polar liquid. Upon application of an electric field, the amount of light passing through the device can be modulated.
    Type: Application
    Filed: June 23, 2026
    Publication date: October 15, 2026
    Inventors: Yu XIA, Dirk HERTEL, Dan LUO, Stephen J. TELFER
  • Publication number: 20260285969
    Abstract: The present invention relates to the fields of treating autoimmune diseases and molecular immunology, and specifically, to an anti-IL-17A antibody, a pharmaceutical composition thereof, and use thereof. More specifically, the present invention relates to a monoclonal antibody or an antigen binding fragment thereof, wherein a heavy chain variable region of the monoclonal antibody comprises: HCDR1-HCDR3 with amino acid sequences set forth in SEQ ID NOs: 31-33 respectively, or HCDR1-HCDR3 with amino acid sequences set forth in SEQ ID NOs: 37-39 respectively, and a light chain variable region of the monoclonal antibody comprises: LCDR1-LCDR3 with amino acid sequences set forth in SEQ ID NO: 34, KVS, and SEQ ID NO: 36, respectively, or LCDR1-LCDR3 with amino acid sequences set forth in SEQ ID NO: 40, LVS, and SEQ ID NO: 42, respectively.
    Type: Application
    Filed: June 4, 2026
    Publication date: September 24, 2026
    Inventors: Baiyong LI, Yu XIA, Zhongmin Maxwell WANG, Peng ZHANG
  • Publication number: 20260274952
    Abstract: An anti-CTLA4 (cytotoxic T lymphocyte associated antigen4) and anti-PD-1 (programmed cell death 1) bifunctional antibody. a pharmaceutical composition thereof and use thereof. Particularly, the anti-CLTA4 and anti-PD-1 bifunctional antibody comprises a first protein functional domain that targets PD-1 and a second protein functional domain that targets CTLA-4. The bifunctional antibody can bind to CTLA-4 and PD-1 specifically, relieve immunosuppression of CTLA4 and PD-1 on an organism specifically, activate T lymphocytes, and thus has good application prospects.
    Type: Application
    Filed: October 21, 2025
    Publication date: September 17, 2026
    Applicant: Akeso Pharmaceuticals, Inc.
    Inventors: Baiyong LI, Yu XIA, Zhongmin Maxwell WANG, Peng ZHANG
  • Publication number: 20260278211
    Abstract: The present disclosure relates to a system and method for generating Computer-Aided Design (CAD) models from natural language descriptions utilizing Large Language Models (LLMs). A universal text-based representation of CAD models is provided, encoding complete Boundary Representation (B-Rep) information. A pre-trained LLM is fine-tuned using a dataset comprising paired natural language descriptions of CAD model creation processes and corresponding universal text-based representations. The fine-tuned LLM converts natural language descriptions into the universal text-based representations, which are subsequently converted into CAD models. The system incorporates solver-based grounding to ensure geometric and topological accuracy and employs Reinforcement Learning from Human Feedback (RLHF) to refine model alignment with expert-defined best practices.
    Type: Application
    Filed: March 15, 2025
    Publication date: September 17, 2026
    Applicant: gNucleus AI, Inc
    Inventor: Yu Xia
  • Publication number: 20260258154
    Abstract: The present invention relates to an anti-PCSK9 antibody preparation and use thereof in medicine. The preparation contains an anti-PCSK9 antibody and a buffer solution. The anti-PCSK9 antibody preparation can effectively inhibit the aggregation of the anti-PCSK9 antibody, thereby preventing the degradation of an antibody product and obtaining a stable injectable pharmaceutical preparation.
    Type: Application
    Filed: June 30, 2023
    Publication date: September 3, 2026
    Inventors: Yu Xia, Zhao Wang, Yu Xia, Baiyong Li
  • Publication number: 20260250389
    Abstract: A pharmaceutical composition comprising an anti-CTLA4-anti-PD-1 bispecific antibody, comprising an anti-CTLA4-anti-PD-1 bispecific antibody, gemcitabine, and optionally paclitaxel (e.g., albumin-bound paclitaxel). The pharmaceutical composition has a good anti-tumor effect.
    Type: Application
    Filed: March 7, 2024
    Publication date: August 27, 2026
    Applicant: AKESO PHARMA CO., LTD.
    Inventors: Yu XIA, Zhongmin WANG, Baiyong LI
  • Publication number: 20260255093
    Abstract: The present disclosure provides a head-mounted device, including: a host; and a wearing apparatus connected to the host, wherein an acoustical device and a wire harness are disposed in the wearing apparatus, and the wire harness is configured to supply power to the host. The wearing apparatus further includes a spacer layer which is between the acoustical device and the wire harness, and the spacer layer is a high magnetic permeability material layer.
    Type: Application
    Filed: August 14, 2023
    Publication date: August 27, 2026
    Inventors: Yu XIA, Jiu XIA, Guanghui LIU, Meng LIU, Jianjun GUO
  • Patent number: 12717201
    Abstract: A variable light transmission device is disclosed and a method of manufacture of the same. The variable light transmission device comprises two light transmissive electrodes and a microcell layer having a plurality of microcells, each microcell comprising a protrusion structure and a channel, and including an electrophoretic medium. The opacity of the device is controlled by an applied electric field.
    Type: Grant
    Filed: December 27, 2023
    Date of Patent: August 25, 2026
    Assignee: E Ink Corporation
    Inventors: Yu Xia, Dirk Hertel, Dan Luo, Stephen J. Telfer
  • Publication number: 20260247680
    Abstract: A method for reducing metal gate corrosion defects is provided. A thicker second hard mask layer is formed at the chamfer on top edge of the isolation layer between the PMOS and NMOS regions, wherein the chamfer sloping toward the NMOS region, as the deposition process creates a thicker layer around step corners. By precisely controlling the etching thickness during subsequent steps, the second hard mask layer in flat regions is removed, while the second hard mask layer at the chamfer is only partially removed, so the remaining second hard mask layer at the chamfer protects the chamfer, reducing the risk of wet cleaning solution penetrating into the metal gate during subsequent wet cleaning of the groove. The present invention addresses corrosion defects caused by chemical reactions between wet cleaning solutions and metal materials such as aluminum, significantly enhancing the performance and reliability of the semiconductor structure.
    Type: Application
    Filed: April 18, 2025
    Publication date: August 20, 2026
    Applicant: Shanghai Huali Integrated Circuit Corporation
    Inventor: Yu XIA
  • Publication number: 20260244047
    Abstract: A switchable light modulator includes an electrophoretic medium for use in a window of an enclosure (e.g., a greenhouse or other building or a vehicle) for light attenuation and heat management. The electrophoretic medium can be driven among a plurality of optical states including: (a) a first set of optical states for reducing transmittance of thermal radiation from incident sunlight through the switchable light modulator into the enclosure, (b) a second set of optical states for promoting transmittance of thermal radiation from the incident sunlight through the switchable light modulator into the enclosure, and (c) a third set of optical states for reducing transmittance of thermal radiation out of the enclosure during nighttime operation.
    Type: Application
    Filed: February 9, 2026
    Publication date: August 20, 2026
    Inventors: Dan LUO, Karl Raymond AMUNDSON, Yu XIA, Stephen J. TELFER
  • Publication number: 20260247686
    Abstract: An HKMG device and a method for manufacturing same. By separately forming the first groove in the PMOS region and the second groove in the NMOS region, depositing the first filling layer in the PMOS region and the second filling layer in the NMOS region, then removing the first and second filling layers through a combination of dry and wet etching and filling the grooves with metal material to respectively form the PMOS and NMOS metal gates, this method allows for precise control over etching depth and range, preventing interface damage to the PMOS region; it eliminates chamfer formation at the junction, prevents wet etching solutions from penetrating the PMOS metal gate, and resolves corrosion defects caused by chemical reactions; furthermore, the PMOS and NMOS work function metal layers are formed stepwise, with chemical mechanical polishing ensuring a uniform surface, significantly enhancing the performance and reliability of the HKMG device.
    Type: Application
    Filed: February 12, 2026
    Publication date: August 20, 2026
    Applicant: Shanghai Huali Integrated Circuit Corporation
    Inventors: Jionghan YE, Yu XIA, Changfeng WANG
  • Publication number: 20260239718
    Abstract: A method for forming a shared contact hole and a semiconductor structure is provided. First, the first hard mask layer is formed on the region where the shared contact hole needs to be formed on the gate structures. Then, the step-by-step etching process ensures that the etching endpoint stops on the first hard mask layer and the second hard mask layer during the etching of the first interlayer dielectric layer, thereby preventing over-etching of the metal gate and the generation of by-products. Subsequently, the first hard mask layer and the second hard mask layer are completely etched to expose portions of the active regions and the metal gate to finally form a shared contact hole. The conductive layer formed in the shared contact hole ensures sufficient contact between the active regions and the metal gate, ultimately improving the yield and reliability of the semiconductor device.
    Type: Application
    Filed: March 27, 2025
    Publication date: August 13, 2026
    Applicant: Shanghai Huali Integrated Circuit Corporation
    Inventors: Yu XIA, Jionghan YE
  • Patent number: 12703743
    Abstract: Provided are an anti-CD47 monoclonal antibody and a use thereof, secreted by the hybridoma cell line with the deposit number CCTCC NO: C2018135.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: August 11, 2026
    Assignee: Akeso Biopharma, Inc.
    Inventors: Peng Zhang, Baiyong Li, Yu Xia, Zhongmin Wang
  • Publication number: 20260225061
    Abstract: Chemical reactions are expedited by exploiting contact electrification at curved microscale interfaces between water and a hydrophobic medium. The hydrophobic medium can be a solid, liquid, or gas. The microscale-interfaces can be surfaces of water droplets in contact with a hydrophobic medium, such as a gas, liquid, or solid, or they can be surfaces of gas microbubbles in contact with water alone or with water containing solid or liquid hydrophobic particles.
    Type: Application
    Filed: January 25, 2024
    Publication date: August 6, 2026
    Inventors: Chanbasha Basheer, Xiaowei Song, Yu Xia, Richard N. Zare
  • Patent number: 12698327
    Abstract: An ant-TIGIT antibody, and a pharmaceutical composition and the use thereof. The present invention relates to an anti-TIGIT antibody or an antigen-binding fragment thereof, wherein a heavy chain variable region of the antibody comprises HCDR1-HCDR3 having amino acid sequences as shown in SEQ ID NOs: 3-5, respectively; and a light chain variable region of the antibody comprises LCDR1-LCDR3 having amino acid sequences as shown in SEQ ID NOs: 8-10, respectively. The antibody can effectively bind to TIGIT and has the potential for use in tumor prevention and treatment.
    Type: Grant
    Filed: October 26, 2021
    Date of Patent: August 4, 2026
    Assignee: AKESO BIOPHARMA, INC.
    Inventors: Baiyong Li, Yu Xia, Zhongmin Wang, Peng Zhang
  • Publication number: 20260217813
    Abstract: The present invention relates to an antibody for treating or preventing autoimmune diseases. The antibody of the present invention comprises a heavy chain variable region set forth in SEQ ID NO:1 or SEQ ID NO:24 and a light chain variable region set forth in SEQ ID NO:6, SEQ ID NO:11, SEQ ID NO:13, SEQ ID NO:15, SEQ ID NO:17 or SEQ ID NO:25.
    Type: Application
    Filed: November 24, 2025
    Publication date: July 30, 2026
    Inventors: Yu Xia, Zhongmin Maxwell Wang, Peng Zhang, Baiyong Li
  • Patent number: 12693568
    Abstract: A variable light transmission device is disclosed, the variable light transmission device comprising two light transmissive electrode layer and a microcell layer having a plurality of microcells. Each of the plurality of microcells includes a first type of electrically charged pigment particles and a second type of electrically charged pigment particles, a charge control agent, and a non-polar liquid. Upon application of an electric field, the amount of light passing through the device can be modulated.
    Type: Grant
    Filed: December 27, 2023
    Date of Patent: July 28, 2026
    Assignee: E Ink Corporation
    Inventors: Yu Xia, Dirk Hertel, Dan Luo, Stephen J. Telfer
  • Publication number: 20260203327
    Abstract: A method, apparatus, non-transitory computer readable medium, and system for obtaining a query comprising a document request. A language generation model is configured to retrieve a first document based on the query and generate an expanded query based on the first document using a knowledge graph that connects the first document to a second document. A third document is retrieved based on the expanded query in response to the query.
    Type: Application
    Filed: January 13, 2025
    Publication date: July 16, 2026
    Inventors: Yu Xia, Sungchul Kim, Ryan A. Rossi, Tong Yu, Haoliang Wang
  • Patent number: 12679887
    Abstract: The present invention relates to the fields of treating autoimmune diseases and molecular immunology, and specifically, to an anti-IL-17A antibody, a pharmaceutical composition thereof, and use thereof. The present invention relates to a monoclonal antibody or an antigen binding fragment thereof, wherein a heavy chain variable region of the monoclonal antibody comprises: HCDR1-HCDR3 with amino acid sequences set forth in SEQ ID NOs: 31-33 respectively, or HCDR1-HCDR3 with amino acid sequences set forth in SEQ ID NOs: 37-39 respectively, and a light chain variable region of the monoclonal antibody comprises: LCDR1-LCDR3 with amino acid sequences set forth in SEQ ID NOs: 34-36 respectively, or LCDR1-LCDR3 with amino acid sequences set forth in SEQ ID NOs: 40-42 respectively. Monoclonal antibodies of the present invention can specifically antagonize the binding of IL-17A to a ligand and inhibit activation of fibroblasts by IL-17A.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: July 14, 2026
    Assignee: Akeso Biopharma, Inc.
    Inventors: Baiyong Li, Yu Xia, Zhongmin Maxwell Wang, Peng Zhang
  • Publication number: 20260177862
    Abstract: A backlight brightness adjustment circuit and a control method therefor, and a device are provided. The circuit comprises: a control end of a first switch component is connected to an output of an AND gate circuit, one end of the first switch component is connected to one end of a first resistor, and the other end of the first switch component is connected to ground; the other end of the first resistor is connected to a first input of a voltage comparator, one end of a second switch component, and one end of a second resistor, and the other end of the second resistor is connected to the ground. Stepless adjustment of the backlight brightness is achieved and the backlight brightness adjustment experience is improved.
    Type: Application
    Filed: March 23, 2023
    Publication date: June 25, 2026
    Inventors: Yu XIA, Guanghui LIU